|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| C07D 519/00 | |||
| A61K 31/437 | |||
| A61P 31/18 |
| (11) | Patento numeris | 3186254 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760003.2 |
| Europos patento paraiškos padavimo data | 2015-08-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/046648 |
| Data | 2015-08-25 |
| (87) | Numeris | WO 2016/033009 |
| Data | 2016-03-03 |
| (30) | Numeris | Data | Šalis |
| 201462042300 P | 2014-08-27 | US |
| (72) |
NAIDU, B. Narasimhulu, US
CONNOLLY, Timothy P., US
EASTMAN, Kyle J., US
PEESE, Kevin, US
|
| (73) |
VIIV Healthcare UK (No.5) Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
| (54) | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION |
| IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION |